Literature DB >> 20798696

Vectoring siRNA therapeutics into the clinic.

Mauro Ferrari.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20798696     DOI： 10.1038/nrclinonc.2010.131

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  Sustained small interfering RNA delivery by mesoporous silicon particles.

Authors:  Takemi Tanaka; Lingegowda S Mangala; Pablo E Vivas-Mejia; René Nieves-Alicea; Aman P Mann; Edna Mora; Hee-Dong Han; Mian M K Shahzad; Xuewu Liu; Rohan Bhavane; Jianhua Gu; Jean R Fakhoury; Ciro Chiappini; Chunhua Lu; Koji Matsuo; Biana Godin; Rebecca L Stone; Alpa M Nick; Gabriel Lopez-Berestein; Anil K Sood; Mauro Ferrari
Journal:  Cancer Res       Date:  2010-05-01       Impact factor: 12.701

2.  Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.

Authors:  Jyotsnabaran Halder; Aparna A Kamat; Charles N Landen; Liz Y Han; Susan K Lutgendorf; Yvonne G Lin; William M Merritt; Nicholas B Jennings; Arturo Chavez-Reyes; Robert L Coleman; David M Gershenson; Rosemarie Schmandt; Steven W Cole; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Clin Cancer Res       Date:  2006-08-15       Impact factor: 12.531

Review 3.  Cancer nanotechnology: opportunities and challenges.

Authors:  Mauro Ferrari
Journal:  Nat Rev Cancer       Date:  2005-03       Impact factor: 60.716

4.  siRNA-mediated gene silencing in vitro and in vivo.

Authors:  Haibin Xia; Qinwen Mao; Henry L Paulson; Beverly L Davidson
Journal:  Nat Biotechnol       Date:  2002-09-16       Impact factor: 54.908

5.  Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.

Authors:  Charles N Landen; Arturo Chavez-Reyes; Corazon Bucana; Rosemarie Schmandt; Michael T Deavers; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Cancer Res       Date:  2005-08-01       Impact factor: 12.701

6.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.

Authors:  Mark E Davis; Jonathan E Zuckerman; Chung Hang J Choi; David Seligson; Anthony Tolcher; Christopher A Alabi; Yun Yen; Jeremy D Heidel; Antoni Ribas
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962

Review 7.  Frontiers in cancer nanomedicine: directing mass transport through biological barriers.

Authors:  Mauro Ferrari
Journal:  Trends Biotechnol       Date:  2010-01-14       Impact factor: 19.536

Review 8.  The promises and pitfalls of RNA-interference-based therapeutics.

Authors:  Daniela Castanotto; John J Rossi
Journal:  Nature       Date:  2009-01-22       Impact factor: 49.962

Review 9.  RNAi therapeutics: a potential new class of pharmaceutical drugs.

Authors:  David Bumcrot; Muthiah Manoharan; Victor Koteliansky; Dinah W Y Sah
Journal:  Nat Chem Biol       Date:  2006-12       Impact factor: 15.040

10.  Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA.

Authors:  Kim A Woodrow; Yen Cu; Carmen J Booth; Jennifer K Saucier-Sawyer; Monica J Wood; W Mark Saltzman
Journal:  Nat Mater       Date:  2009-05-03       Impact factor: 43.841
  10 in total
  12 in total

Review 1.  Molecular-targeted nanotherapies in cancer: enabling treatment specificity.

Authors:  Elvin Blanco; Angela Hsiao; Guillermo U Ruiz-Esparza; Matthew G Landry; Funda Meric-Bernstam; Mauro Ferrari
Journal:  Mol Oncol       Date:  2011-10-25       Impact factor: 6.603

Review 2.  Magnetic nanoparticles for cancer diagnosis and therapy.

Authors:  Mehmet V Yigit; Anna Moore; Zdravka Medarova
Journal:  Pharm Res       Date:  2012-01-25       Impact factor: 4.200

3.  Ultrasound-assisted siRNA delivery via arginine-grafted bioreducible polymer and microbubbles targeting VEGF for ovarian cancer treatment.

Authors:  Stelios Florinas; Jaesung Kim; Kihoon Nam; Margit M Janát-Amsbury; Sung Wan Kim
Journal:  J Control Release       Date:  2014-03-21       Impact factor: 9.776

4.  Multistage vectored siRNA targeting ataxia-telangiectasia mutated for breast cancer therapy.

Authors:  Rong Xu; Yi Huang; Junhua Mai; Guodong Zhang; Xiaojing Guo; Xiaojun Xia; Eugene J Koay; Guoting Qin; Donald R Erm; Qingpo Li; Xuewu Liu; Mauro Ferrari; Haifa Shen
Journal:  Small       Date:  2013-01-06       Impact factor: 13.281

Review 5.  What does physics have to do with cancer?

Authors:  Franziska Michor; Jan Liphardt; Mauro Ferrari; Jonathan Widom
Journal:  Nat Rev Cancer       Date:  2011-08-18       Impact factor: 60.716

6.  Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery.

Authors:  Haifa Shen; Cristian Rodriguez-Aguayo; Rong Xu; Vianey Gonzalez-Villasana; Junhua Mai; Yi Huang; Guodong Zhang; Xiaojing Guo; Litao Bai; Guoting Qin; Xiaoyong Deng; Qingpo Li; Donald R Erm; Burcu Aslan; Xuewu Liu; Jason Sakamoto; Arturo Chavez-Reyes; Hee-Dong Han; Anil K Sood; Mauro Ferrari; Gabriel Lopez-Berestein
Journal:  Clin Cancer Res       Date:  2013-02-05       Impact factor: 12.531

Review 7.  Silicon micro- and nanofabrication for medicine.

Authors:  Daniel Fine; Alessandro Grattoni; Randy Goodall; Shyam S Bansal; Ciro Chiappini; Sharath Hosali; Anne L van de Ven; Srimeenkashi Srinivasan; Xuewu Liu; Biana Godin; Louis Brousseau; Iman K Yazdi; Joseph Fernandez-Moure; Ennio Tasciotti; Hung-Jen Wu; Ye Hu; Steve Klemm; Mauro Ferrari
Journal:  Adv Healthc Mater       Date:  2013-04-15       Impact factor: 9.933

8.  Endosomal escape and siRNA delivery with cationic shell crosslinked knedel-like nanoparticles with tunable buffering capacities.

Authors:  Ritu Shrestha; Mahmoud Elsabahy; Stephanie Florez-Malaver; Sandani Samarajeewa; Karen L Wooley
Journal:  Biomaterials       Date:  2012-08-16       Impact factor: 12.479

9.  Cooperative, nanoparticle-enabled thermal therapy of breast cancer.

Authors:  Haifa Shen; Jian You; Guodong Zhang; Arturas Ziemys; Qingpo Li; Litao Bai; Xiaoyong Deng; Donald R Erm; Xuewu Liu; Chun Li; Mauro Ferrari
Journal:  Adv Healthc Mater       Date:  2011-11-29       Impact factor: 9.933

Review 10.  Delivery of gene silencing agents for breast cancer therapy.

Authors:  Haifa Shen; Vivek Mittal; Mauro Ferrari; Jenny Chang
Journal:  Breast Cancer Res       Date:  2013-05-08       Impact factor: 6.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.